Comment on

• Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy.

  Lopez-Jaramillo P, Joseph P, Lopez-Lopez JP, Lanas F, Avezum A, Diaz R, Camacho PA, Seron P, Oliveira G, Orlandini A, Rangarajan S, Islam S, Yusuf S. Lopez-Jaramillo P, et al. Eur Heart J. 2022 Aug 7;43(30):2841-2851. doi: 10.1093/eurheartj/ehac113. Eur Heart J. 2022. PMID: 35325078
• Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy.

  Li S, Liu Z, Joseph P, Hu B, Yin L, Tse LA, Rangarajan S, Wang C, Wang Y, Islam S, Liu W, Lu F, Li Y, Hou Y, Qiang D, Zhao Q, Li N, Lei R, Chen D, Han A, Liu G, Zhang P, Zhi Y, Liu C, Yang J, Resalaiti A, Ma H, Ma Y, Liu Y, Xing X, Xiang Q, Liu Z, Sheng Y, Tang J, Liu L, Yusuf S, Li W. Li S, et al. Eur Heart J. 2022 Aug 7;43(30):2852-2863. doi: 10.1093/eurheartj/ehac268. Eur Heart J. 2022. PMID: 35731140
• Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy.

  Joseph P, Kutty VR, Mohan V, Kumar R, Mony P, Vijayakumar K, Islam S, Iqbal R, Kazmi K, Rahman O, Yusuf R, Anjana RM, Mohan I, Rangarajan S, Gupta R, Yusuf S. Joseph P, et al. Eur Heart J. 2022 Aug 7;43(30):2831-2840. doi: 10.1093/eurheartj/ehac249. Eur Heart J. 2022. PMID: 35731159